Kumar AP - Search Results

1

Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy.

Paskeh MDA, Saebfar H, Mahabady MK, Orouei S, Hushmandi K, Entezari M, Hashemi M, Aref AR, Hamblin MR, Ang HL, Kumar AP, Zarrabi A, Samarghandian S. Paskeh MDA, et al. Among authors: kumar ap. Life Sci. 2022 Jun 1;298:120463. doi: 10.1016/j.lfs.2022.120463. Epub 2022 Mar 6. Life Sci. 2022. PMID: 35259354 Review.

2

NF-κB in cancer therapy.

Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. Li F, et al. Among authors: kumar ap. Arch Toxicol. 2015 May;89(5):711-31. doi: 10.1007/s00204-015-1470-4. Epub 2015 Feb 18. Arch Toxicol. 2015. PMID: 25690730 Review.

3

The Role of Resveratrol in Cancer Therapy.

Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. Ko JH, et al. Among authors: kumar ap. Int J Mol Sci. 2017 Dec 1;18(12):2589. doi: 10.3390/ijms18122589. Int J Mol Sci. 2017. PMID: 29194365 Free PMC article. Review.

4

Magneto-Fluorescent Perovskite Nanocomposites for Directed Cell Motion and Imaging.

Tan MJH, Ravichandran D, Ang HL, Ong EWY, Lim CQX, Kam GMQ, Kumar AP, Tan ZK. Tan MJH, et al. Among authors: kumar ap. Adv Healthc Mater. 2019 Dec;8(23):e1900859. doi: 10.1002/adhm.201900859. Epub 2019 Nov 7. Adv Healthc Mater. 2019. PMID: 31697051

5

Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.

Reddy D, Kumavath R, Tan TZ, Ampasala DR, Kumar AP. Reddy D, et al. Among authors: kumar ap. Life Sci. 2020 Jan 15;241:117147. doi: 10.1016/j.lfs.2019.117147. Epub 2019 Dec 9. Life Sci. 2020. PMID: 31830480

6

Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Harsha C, Banik K, Ang HL, Girisa S, Vikkurthi R, Parama D, Rana V, Shabnam B, Khatoon E, Kumar AP, Kunnumakkara AB. Harsha C, et al. Among authors: kumar ap. Int J Mol Sci. 2020 May 6;21(9):3285. doi: 10.3390/ijms21093285. Int J Mol Sci. 2020. PMID: 32384682 Free PMC article. Review.

7

MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Ashrafizadeh M, Ang HL, Moghadam ER, Mohammadi S, Zarrin V, Hushmandi K, Samarghandian S, Zarrabi A, Najafi M, Mohammadinejad R, Kumar AP. Ashrafizadeh M, et al. Among authors: kumar ap. Biomolecules. 2020 Jul 12;10(7):1040. doi: 10.3390/biom10071040. Biomolecules. 2020. PMID: 32664703 Free PMC article. Review.

8

PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation.

Ashrafizadeh M, Najafi M, Ang HL, Moghadam ER, Mahabady MK, Zabolian A, Jafaripour L, Bejandi AK, Hushmandi K, Saleki H, Zarrabi A, Kumar AP. Ashrafizadeh M, et al. Among authors: kumar ap. Biomedicines. 2020 Aug 3;8(8):264. doi: 10.3390/biomedicines8080264. Biomedicines. 2020. PMID: 32756305 Free PMC article. Review.

9

Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.

Ashrafizadeh M, Hushmandi K, Hashemi M, Akbari ME, Kubatka P, Raei M, Koklesova L, Shahinozzaman M, Mohammadinejad R, Najafi M, Sethi G, Kumar AP, Zarrabi A. Ashrafizadeh M, et al. Among authors: kumar ap. Biomolecules. 2020 Aug 7;10(8):1159. doi: 10.3390/biom10081159. Biomolecules. 2020. PMID: 32784711 Free PMC article. Review.

10

Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Moghadam ER, Ang HL, Asnaf SE, Zabolian A, Saleki H, Yavari M, Esmaeili H, Zarrabi A, Ashrafizadeh M, Kumar AP. Moghadam ER, et al. Among authors: kumar ap. Biomolecules. 2020 Sep 27;10(10):1374. doi: 10.3390/biom10101374. Biomolecules. 2020. PMID: 32992587 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page